BrightView (BV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Jan, 2026Executive summary
The 2026 Annual Meeting will be held virtually on March 3, 2026, with voting available online, by phone, or mail.
Stockholders will vote on the election of seven directors, ratification of Deloitte & Touche LLP as auditor, and other business.
Series A Preferred Stockholders have special voting rights, including electing two additional directors designated by One Rock affiliates.
The record date for voting is January 7, 2026, with 94,491,213 Common Stock shares and 500,000 Series A Preferred Stock shares outstanding.
Voting matters and shareholder proposals
Proposals include electing seven directors (by all stockholders) and two additional directors (by Series A Preferred Stockholders), and ratifying Deloitte & Touche LLP as auditor for fiscal 2026.
Stockholders may submit proposals for the 2027 meeting by September 17, 2026, and director nominations between November 3 and December 3, 2026.
Proxy voting is recommended for all stockholders, with the Board supporting all nominees and the auditor ratification.
Board of directors and corporate governance
The Board consists of nine directors, eight of whom are independent; all are elected annually.
Board committees include Audit, Compensation, and Nominating & Corporate Governance, all composed of independent directors.
The Board is led by a separate Chairman and CEO, and follows NYSE and SEC governance standards.
Investors (One Rock) have the right to designate two directors as long as they hold at least 60% of Series A Preferred Stock; this right reduces as their ownership declines.
The Board emphasizes diversity, experience, and independence in director nominations.
Latest events from BrightView
- Profitable growth driven by scale, recurring revenue, and transformation in a $140B market.BV
Investor presentation16 Mar 2026 - Revenue up 2.6%-3% to $615M, net loss widens, guidance reaffirmed for 2026.BV
Q1 20264 Feb 2026 - Record EBITDA, margin gains, and debt reduction drive raised free cash flow guidance.BV
Q3 20242 Feb 2026 - Shareholders will vote on director elections and auditor ratification at the March 2026 virtual meeting.BV
Proxy Filing15 Jan 2026 - Record Adjusted EBITDA, margin gains, and lower leverage set stage for continued growth.BV
Q4 202414 Jan 2026 - Targeting ~$4B revenue and 16%+ EBITDA margin by 2030 through unified strategy and efficiencies.BV
Investor Day 202527 Dec 2025 - Adjusted EBITDA up 11.6% and margin expands despite 4.4% revenue decline in Q1 2025.BV
Q1 202518 Dec 2025 - Major investors may sell preferred and common shares; Series A Preferred Stock offers 7% yield and conversion rights.BV
Registration Filing16 Dec 2025 - Annual meeting covers director elections, auditor, executive pay, and major ESG initiatives.BV
Proxy Filing1 Dec 2025